Document is current
Any future updates will be listed below
-
Authors
Mørch, Nina Freiesleben https://orcid.org/0000-0001-7104-5722
Nøhr, Bugge https://orcid.org/0009-0009-9744-4452
Rode, Line https://orcid.org/0000-0002-9080-3389
Klajnbard, Anna
Kiilerich, Pia https://orcid.org/0000-0001-5665-6074
Hedley, Paula https://orcid.org/0000-0001-5801-960X
Christiansen, Michael https://orcid.org/0000-0003-4713-755X
Svendsen, Pernille Fog https://orcid.org/0000-0002-8534-7868
- License Information
-
More Information
Article History
Received: 30 May 2025
Accepted: 21 October 2025
First Online: 11 November 2025
Declarations
:
: Approval was obtained from the ethics committee of the Regional Scientific Ethics Committee, Capitol Region, Denmark. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study, and data on the newborns was obtained with written consent from the parents.
: LR, PK, PH, and MC have no conflicts to declare. NM has received funding for congress participation from Gedeon Richter Nordics AB and Merck A/S, outside of the current work. BN has received grants from Merck A/S, Gedeon Richter Nordics AB, and Ferring Pharmaceuticals A/S, along with personal fees from Ferring Pharmaceuticals A/S, travel support from Gedeon Richter Nordics AB, and has participated in a data safety monitoring or advisory board for Ferring Pharmaceuticals A/S, outside of this research. AK has, outside this work, received payment from Organon and Merck A/S for educational presentations and travel support from Merck A/S and Ferring Pharmaceuticals A/S. PS has received grants from Merck A/S, Gedeon Richter Nordics AB, and Ferring Pharmaceuticals A/S, as well as travel support from Ferring Pharmaceuticals A/S, outside of this study.
